|
The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability
|
journal
|
September 2007 |
|
NanoBRET—A Novel BRET Platform for the Analysis of Protein–Protein Interactions
|
journal
|
June 2015 |
|
Role of YAP/TAZ in mechanotransduction
|
journal
|
June 2011 |
|
Concentration Measurement by Proton NMR Using the ERETIC Method
|
journal
|
July 1999 |
|
Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
|
journal
|
June 2012 |
|
Physical Interaction with Yes-associated Protein Enhances p73 Transcriptional Activity
|
journal
|
January 2001 |
|
Emerging roles of TEAD transcription factors and its coactivators in cancers
|
journal
|
May 2013 |
|
1H-Imidazole-2,5-Dicarboxamides as NS4A Peptidomimetics: Identification of a New Approach to Inhibit HCV-NS3 Protease
|
journal
|
March 2020 |
|
Palmitoylation of TEAD Transcription Factors Is Required for Their Stability and Function in Hippo Pathway Signaling
|
journal
|
January 2016 |
|
Targeting Hippo pathway by specific interruption of YAP‐TEAD interaction using cyclic YAP‐like peptides
|
journal
|
November 2014 |
|
Regulation of cellular quiescence by YAP/TAZ and Cyclin E1 in colon cancer cells: Implication in chemoresistance and cancer relapse
|
journal
|
August 2016 |
|
Integrative genomics analysis reveals the multilevel dysregulation and oncogenic characteristics of TEAD4 in gastric cancer
|
journal
|
December 2013 |
|
The Hippo Signaling Pathway in Development and Cancer
|
journal
|
October 2010 |
|
Increased TEAD4 expression and nuclear localization in colorectal cancer promote epithelial–mesenchymal transition and metastasis in a YAP-independent manner
|
journal
|
September 2015 |
|
Cell contact and Nf2/Merlin-dependent regulation of TEAD palmitoylation and activity
|
journal
|
May 2019 |
|
Autopalmitoylation of TEAD proteins regulates transcriptional output of the Hippo pathway
|
journal
|
February 2016 |
|
Ligand-Based Fluorine NMR Screening: Principles and Applications in Drug Discovery Projects
|
journal
|
October 2018 |
|
Antiproliferative and Antimigratory Effects of a Novel YAP–TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking
|
journal
|
January 2019 |
|
Both TEAD-Binding and WW Domains Are Required for the Growth Stimulation and Oncogenic Transformation Activity of Yes-Associated Protein
|
journal
|
January 2009 |
|
The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment
|
journal
|
December 2013 |
|
TEAD mediates YAP-dependent gene induction and growth control
|
journal
|
July 2008 |
|
Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination
|
journal
|
October 2006 |
|
YAP/TAZ at the Roots of Cancer
|
journal
|
June 2016 |
|
Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin
|
journal
|
January 2011 |
|
Ligands to the (IRAP)/AT4 receptor encompassing a 4-hydroxydiphenylmethane scaffold replacing Tyr2
|
journal
|
July 2008 |
|
Structural and ligand-binding analysis of the YAP-binding domain of transcription factor TEAD4
|
journal
|
June 2018 |
|
Targeting the Central Pocket in Human Transcription Factor TEAD as a Potential Cancer Therapeutic Strategy
|
journal
|
November 2015 |
|
YAP/TAZ for cancer therapy: Opportunities and challenges (Review)
|
journal
|
February 2015 |
|
YAP and the Hippo pathway in pediatric cancer
|
journal
|
February 2017 |
|
Identification of Quinolinols as Activators of TEAD-Dependent Transcription
|
journal
|
November 2019 |
|
Design of a Chemical Probe for the Bromodomain and Plant Homeodomain Finger-Containing (BRPF) Family of Proteins
|
journal
|
August 2017 |
|
AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma
|
journal
|
November 2010 |
|
Effect of the acylation of TEAD4 on its interaction with co-activators YAP and TAZ: TEAD Acylation
|
journal
|
November 2017 |
|
Structure-Based Design and Synthesis of Potent Cyclic Peptides Inhibiting the YAP–TEAD Protein–Protein Interaction
|
journal
|
July 2014 |
|
Synthesis and reactions of some 5(6)-(1-adamantyl)benzimidazoles
|
journal
|
August 2008 |
|
Synthesis of fluorinated analogues of sphingosine-1-phosphate antagonists as potential radiotracers for molecular imaging using positron emission tomography
|
journal
|
October 2014 |
|
Current NMR Techniques for Structure-Based Drug Discovery
|
journal
|
January 2018 |
|
The Biology of YAP/TAZ: Hippo Signaling and Beyond
|
journal
|
October 2014 |
|
Novel Flufenamic Acid Analogues as Inhibitors of Androgen Receptor Mediated Transcription
|
journal
|
August 2009 |
|
DNA binding partners of YAP/TAZ
|
journal
|
March 2018 |
|
A Supramolecular Microfluidic Optical Chemosensor
|
journal
|
February 2002 |
|
Small Molecule Dysregulation of TEAD Lipidation Induces a Dominant-Negative Inhibition of Hippo Pathway Signaling
|
journal
|
June 2020 |
|
New N -Arachidonoylserotonin Analogues with Potential “Dual” Mechanism of Action against Pain
|
journal
|
November 2007 |
|
Structural Basis of Inhibitor Specificity of the Human Protooncogene Proviral Insertion Site in Moloney Murine Leukemia Virus (PIM-1) Kinase
|
journal
|
October 2005 |
|
4-(1-Adamantyl)phenylalkylamines with Potential Antiproliferative Activity
|
journal
|
February 2016 |
|
The preparation of 3-substituted-1,5-dibromopentanes as precursors to heteracyclohexanes
|
journal
|
January 2011 |
|
Elucidation of a Universal Size-Control Mechanism in Drosophila and Mammals
|
journal
|
September 2007 |
|
Structure-based design of potent linear peptide inhibitors of the YAP-TEAD protein-protein interaction derived from the YAP omega-loop sequence
|
journal
|
August 2019 |
|
High Cancer-Specific Expression of Mesothelin ( MSLN ) Is Attributable to an Upstream Enhancer Containing a Transcription Enhancer Factor–Dependent MCAT Motif
|
journal
|
October 2007 |
|
A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer
|
journal
|
February 2014 |
|
Small-Molecule Covalent Modification of Conserved Cysteine Leads to Allosteric Inhibition of the TEAD⋅Yap Protein-Protein Interaction
|
journal
|
March 2019 |
|
TEAD–YAP Interaction Inhibitors and MDM2 Binders from DNA‐Encoded Indole‐Focused Ugi Peptidomimetics
|
journal
|
July 2020 |
|
The Salvador–Warts–Hippo pathway — an emerging tumour-suppressor network
|
journal
|
March 2007 |
|
YAP/TAZ Activation as a Target for Treating Metastatic Cancer
|
journal
|
April 2018 |
|
Pd II ‐Catalyzed Monoselective ortho Halogenation of CH Bonds Assisted by Counter Cations: A Complementary Method to Directed ortho Lithiation
|
journal
|
June 2008 |
|
Discovery and biological evaluation of vinylsulfonamide derivatives as highly potent, covalent TEAD autopalmitoylation inhibitors
|
journal
|
December 2019 |
|
Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
|
journal
|
December 2017 |
|
Toward the Discovery of a Novel Class of YAP–TEAD Interaction Inhibitors by Virtual Screening Approach Targeting YAP–TEAD Protein–Protein Interface
|
journal
|
May 2018 |
|
Structural insights into the YAP and TEAD complex
|
journal
|
February 2010 |
|
Structural Insights into the Regulation of Hippo Signaling
|
journal
|
February 2017 |
|
Protein-Protein Interaction Disruptors of the YAP/TAZ-TEAD Transcriptional Complex
|
journal
|
December 2020 |
|
TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer
|
journal
|
November 2008 |
|
The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version
|
journal
|
May 2010 |